Yan Wang
6PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 22, 2026
CDK2 inhibitor BLU-222 synergizes with CDK4/6 inhibitors in drug resistant breast cancers through p21/p27 induction.Linjie Luo, Yan Wang, Tuyen Bui
|Dec 24, 2025
Rb1 deficiency induces synthetic lethality with ATR and PKMYT1 coinhibition in breast cancer cell lines and patient-derived xenografts.Xiao-Ting Jiang, Mei-Kuang Chen, Jiwang Lee
|Jan 26, 2025
Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2- breast cancer.Akshara Singareeka Raghavendra, Nicole M Kettner, Danielle Kwiatkowski
|Aug 26, 2024
Low-Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer.Mi Li, Amriti R Lulla, Yan Wang
|Jun 29, 2023
Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor-Positive Metastatic Breast Cancers.Juliana Navarro-Yepes, Nicole M Kettner, Xiayu Rao
|Jan 05, 2023
Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time.Tuyen Duong Thanh Nguyen, Yan Wang, Tuyen N Bui
Pageof 1
Frequent Collaborators
6 joint publications
Khandan Keyomarsi
6 joint publications
Kelly K Hunt
4 joint publications
Nicole M Kettner
3 joint publications
Tuyen N Bui
3 joint publications
Jing Wang
3 joint publications
Linjie Luo
3 joint publications
Mei-Kuang Chen
3 joint publications
Mi Li
2 joint publications
Tuyen Duong Thanh Nguyen
2 joint publications
Akshara Singareeka Raghavendra
